This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by von Hertzen, L. Articles by Saikku, P. Search for Related Content PubMed PubMed Citation Articles by von Hertzen, L. Articles by Saikku, P.

 Previous Article  |  Next Article 

Clinical and Diagnostic Laboratory Immunology, 07 1995, 454-457, Vol 2, No. 4
Copyright © 1995 by the American Society for Microbiology. All rights reserved.

Measurement of sputum antibodies in the diagnosis of acute and chronic respiratory infections associated with Chlamydia pneumoniae

L von Hertzen, M Leinonen, HM Surcel, J Karjalainen and P Saikku
National Public Health Institute, Helsinki, Finland.

The aim of this study was to develop methods for the measurement of sputum antibodies in the laboratory diagnosis of acute and chronic lower respiratory tract infections caused by Chlamydia pneumoniae. Paired serum specimens, sputum specimens, and pharyngeal or nasopharyngeal swabs were obtained from 97 patients; 51 of them had community-acquired pneumonia, and 46 had chronic obstructive pulmonary disease (COPD). C. pneumoniae-specific serum immunoglobulin G (IgG), IgA, and IgM antibodies were measured by the microimmunofluorescence (micro-IF) test. For sputa, specific IgA and IgG antibodies were measured by the micro-IF test and secretory IgA (sIgA) was measured by enzyme immune assay (EIA) with C. pneumoniae elementary bodies as the antigen. Sputum IgA and sIgA antibodies to C. pneumoniae were found, respectively, in 52 and 51% of the COPD patients. Elevated levels of stable serum IgG and IgA antibodies (IgG titer of > or = 128 and IgA titer of > or = 40), suggesting chronic infection, were found in 54% of the COPD patients. The sensitivity for the sputum IgA micro-IF test compared with elevated serum antibody levels was 87.5%, and that for the sputum sIgA EIA was 88%; the respective specificities were 90 and 95%. Acute C. pneumoniae infection was diagnosed in seven pneumonia patients, and two (29%) of these patients were positive by sputum EIA antibody measurements. Two pneumonia patients without acute infection had stable elevated IgG and IgA levels in their sera, and both of them were sputum antibody positive.(ABSTRACT TRUNCATED AT 250 WORDS)

This article has been cited by other articles:

• Uruma, T., Yamaguchi, H., Fukuda, M., Kawakami, H., Goto, H., Kishimoto, T., Yamamoto, Y., Tomoda, A., Kamiya, S. (2005). Chlamydia pneumoniae growth inhibition in human monocytic THP-1 cells and human epithelial HEp-2 cells by a novel phenoxazine derivative. J Med Microbiol 54: 1143-1149 [Abstract] [Full Text]  
• Ciervo, A., Visca, P., Petrucca, A., Biasucci, L. M., Maseri, A., Cassone, A. (2002). Antibodies to 60-Kilodalton Heat Shock Protein and Outer Membrane Protein 2 of Chlamydia pneumoniae in Patients with Coronary Heart Disease. CVI 9: 66-74 [Abstract] [Full Text]  
• Airenne, S., Surcel, H.-M., Alakarppa, H., Laitinen, K., Paavonen, J., Saikku, P., Laurila, A. (1999). Chlamydia pneumoniae Infection in Human Monocytes. Infect. Immun. 67: 1445-1449 [Abstract] [Full Text]  
• Laurila, A., Bloigu, A., Nayha, S., Hassi, J., Leinonen, M., Saikku, P. (1997). Chronic Chlamydia pneumoniae Infection Is Associated With a Serum Lipid Profile Known to Be a Risk Factor for Atherosclerosis. Arterioscler. Thromb. Vasc. Bio. 17: 2910-2913 [Abstract] [Full Text]